Contrasting CochLear (OTCMKTS:CHEOY) & Establishment Labs (NASDAQ:ESTA)

CochLear (OTCMKTS:CHEOY) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Risk and Volatility

CochLear has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for CochLear and Establishment Labs, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CochLear	0	2	1	2	3.00
Establishment Labs	1	1	6	0	2.63

Establishment Labs has a consensus target price of $86.86, indicating a potential upside of 40.07%. Given Establishment Labs’ higher possible upside, analysts plainly believe Establishment Labs is more favorable than CochLear.

Valuation & Earnings

This table compares CochLear and Establishment Labs”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CochLear	$1.53 billion	5.35	$251.85 million	N/A	N/A
Establishment Labs	$211.08 million	8.61	-$51.06 million	($1.74)	-35.64

CochLear has higher revenue and earnings than Establishment Labs.

Profitability

This table compares CochLear and Establishment Labs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CochLear	N/A	N/A	N/A
Establishment Labs	-24.19%	-201.79%	-15.03%

Institutional and Insider Ownership

72.9% of Establishment Labs shares are owned by institutional investors. 11.4% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

CochLear beats Establishment Labs on 8 of the 13 factors compared between the two stocks.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.